|Bid||38.84 x 800|
|Ask||38.98 x 800|
|Day's Range||36.92 - 39.19|
|52 Week Range||32.96 - 101.30|
|Beta (5Y Monthly)||1.04|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 02, 2023 - May 08, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||70.87|
Subscribe to Yahoo Finance Plus to view Fair Value for MRTX
Mirati Therapeutics, Inc. (NASDAQ: MRTX), a commercial stage biotechnology company, will participate at the Barclays Global Healthcare Conference on March 14 at 6:00 a.m. P.T. / 9:00 a.m. E.T. Ben Hickey, chief commercial officer, and Alan Sandler, chief medical officer, will represent the company in a fireside chat at the conference.
One thing we could say about the analysts on Mirati Therapeutics, Inc. ( NASDAQ:MRTX ) - they aren't optimistic, having...
Mirati Therapeutics, Inc. (NASDAQ:MRTX) Q4 2022 Earnings Call Transcript February 28, 2023 Operator: Good afternoon and welcome to the Mirati Therapeutics Fourth Quarter 2022 Earnings Call. My name is Cynthia and I’ll be the operator for today’s call. It is my pleasure to introduce Ryan Asay, Vice President of Corporate Affairs at Mirati. Ryan, you […]